1. Home
  2. III vs MSLE Comparison

III vs MSLE Comparison

Compare III & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$6.18

Market Cap

197.1M

ML Signal

HOLD

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

HOLD

Current Price

$6.52

Market Cap

186.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
III
MSLE
Founded
2006
2018
Country
United States
Canada
Employees
1500
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
197.1M
186.9M
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
III
MSLE
Price
$6.18
$6.52
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$6.80
★ $24.17
AVG Volume (30 Days)
★ 222.1K
64.2K
Earning Date
11-02-2026
11-15-2026
Dividend Yield
★ 2.92%
N/A
EPS Growth
★ 216.67
N/A
EPS
★ 0.12
N/A
Revenue
★ $192,745,000.00
N/A
Revenue This Year
$4.24
N/A
Revenue Next Year
$3.59
N/A
P/E Ratio
$51.50
★ N/A
Revenue Growth
★ 4.51
N/A
52 Week Low
$3.74
$5.44
52 Week High
$6.45
$13.39

Technical Indicators

Market Signals
Indicator
III
MSLE
Relative Strength Index (RSI) 73.47 32.08
Support Level $3.86 $5.52
Resistance Level N/A $10.58
Average True Range (ATR) 0.18 0.58
MACD 0.02 -0.02
Stochastic Oscillator 92.59 7.39

Price Performance

Historical Comparison
III
MSLE

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: